{"id":"tp-53619","type":"article-newspaper","title":"AbCellera Plans 2027 Late-Stage Development for ABCL635","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/53619","datePublished":"2026-11-11T05:54:50.000Z","dateModified":"2026-11-11T05:54:50.000Z","language":"en","abstract":"A Phase 2 study found a placebo-adjusted reduction of 5.3 moderate-to-severe hot flashes per day at week four. AbCellera listed more than $890 million in available liquidity as of Sept. 30.","section":"Business","references":[{"title":"quarterly results showing $10.6 million in revenue and a $0.13 net loss per share","url":"https://www.tokenpost.com/news/business/53382"}]}